Institutional Fund
Foresite Capital Management V, LLC
West Hollywood, CACIK 17922065 filings on record
Portfolio Value
$271.00M
Q1 2026
Holdings
9
Reported positions
New Buys
3
Opened this quarter
QoQ Change
+64.8%
from $164.40M
Portfolio Value Trend
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeTop Allocations
Largest positions by weight
- Alumis Inc47.9%
- Cg Oncology Inc25.1%
- Disc Medicine Inc8.8%
- Hims & Hers Health Inc5.7%
- Eikon Therapeutics Inc5.1%
- Lyell Immunopharma Inc3.5%
- Other3.8%
Portfolio Holdings
9 positions · Q1 2026
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Alumis Inc | 5.90M | $129.91M | 47.9% | +117.6K | Added |
| 2 | Cg Oncology Inc | 1.00M | $67.95M | 25.1% | 0 | Held |
| 3 | Disc Medicine Inc | 374.1K | $23.92M | 8.8% | +75.0K | Added |
| 4 | Hims & Hers Health Inc | 738.2K | $15.32M | 5.7% | +465.0K | Added |
| 5 | Eikon Therapeutics Inc | 1.32M | $13.95M | 5.1% | +1.32M | New |
| 6 | Lyell Immunopharma Inc | 477.1K | $9.57M | 3.5% | 0 | Held |
| 7 | Pharvaris N V | 194.1K | $5.48M | 2.0% | +194.1K | New |
| 8 | Nurix Therapeutics Inc | 265.0K | $4.11M | 1.5% | +265.0K | New |
| 9 | Maze Therapeutics Inc | 25.9K | $773.3K | 0.3% | −60.4K | Reduced |